It is important to be honest about what to expect, and we always are
At our clinic, one of our IV specialist Registered Nurses will consult with you on the optimum therapy to help you achieve your goals and feel your best
Initial resistance to the idea of permanent medication gradually shifted as they experienced sustained results and improved quality of life
FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
Many of the most important signs show up before major changes on the scale, which is why providers focus on a broader set of signals rather than day-to-day numbers
[PUBMED Abstract] Small EJ, Schellhammer PF, Higano CS, et al.: Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer